A Randomised Single Blind Study Comparing the Molar Median Effective Dose of Levobupivacaine and Molar Median Effective Dose of Ropivacaine When Administered as a Femoral Perineural Infusion for Pain Relief After Total Knee Replacement
Phase of Trial: Phase IV
Latest Information Update: 15 May 2018
At a glance
- Drugs Levobupivacaine (Primary) ; Ropivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 28 Mar 2012 Primary endpoint identified as (Verbal rating scale) as reported by European Clinical Trials Database record.
- 23 Nov 2011 Location (Scotland) added as reported by ClinicalTrials.gov.
- 23 Nov 2011 Company Tenovus added in associations field as reported by United Kingdom Clinical Research Network record.